Schall Law Firm

Recent News

  • SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Argo Blockchain plc with Losses of $100,000 to Contact the Firm

    Los Angeles, California--(Newsfile Corp. - January 27, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Argo Blockchain plc ("Argo" or "the Company") (NASDAQ: ARBK) for violations of the federal securities laws.Investors who purchased the Company's American Depository Shares ("ADSs") pursuant and/or traceable to the Company's initial public offering conducted on September 23, 2021 (the "IPO") and/or between September 23, 2021 and October 10, 2022, both dates inclusive...

    2023-01-27 12:00 PM EST
  • INVESTIGATION NOTICE: The Schall Law Firm Announces It is Investigating Claims Against Surmodics, Inc. and Encourages Investors with Losses to Contact the Firm

    Los Angeles, California--(Newsfile Corp. - January 27, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surmodics, Inc. ("Surmodics" or "the Company") (NASDAQ: SRDX) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Surmodics announced on January 19, 2023, that it had received a letter from the FDA related to...

    2023-01-27 9:51 AM EST
  • SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Y-mAbs Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

    Los Angeles, California--(Newsfile Corp. - January 27, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Y-mAbs Therapeutics, Inc. ("Y-mAbs" or "the Company") (NASDAQ: YMAB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between October 6, 2020 and October 28, 2022, inclusive (the ''Class Period''), are encouraged...

    2023-01-27 8:35 AM EST
  • 7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

    Los Angeles, California--(Newsfile Corp. - January 27, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Spectrum Pharmaceuticals, Inc. ("Spectrum" or "the Company") (NASDAQ: SPPI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between December 6, 2021 and September 22, 2022, inclusive (the ''Class Period''), are encouraged...

    2023-01-27 8:20 AM EST
  • 7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in Veru Inc. with Losses of $100,000 to Contact the Firm

    Los Angeles, California--(Newsfile Corp. - January 27, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Veru Inc. ("Veru" or "the Company") (NASDAQ: VERU) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between May 11, 2022 and November 9, 2022, inclusive (the ''Class Period''), are encouraged to...

    2023-01-27 8:10 AM EST
  • 7-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in The Gap, Inc. with Losses of $100,000 to Contact the Firm

    Los Angeles, California--(Newsfile Corp. - January 27, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against The Gap, Inc. ("Gap" or "the Company") (NYSE: GPS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between November 24, 2021 and July 11, 2022, inclusive (the ''Class Period''), are encouraged...

    2023-01-27 8:00 AM EST
  • SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Fate Therapeutics, Inc. with Losses of $100,000 to Contact the Firm

    Los Angeles, California--(Newsfile Corp. - January 26, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Fate Therapeutics, Inc. ("Fate" or "the Company") (NASDAQ: FATE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between April 2, 2020 and January 5, 2023, inclusive (the ''Class Period''), are encouraged...

    2023-01-26 12:08 PM EST
  • SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Sotera Health Company with Losses of $100,000 to Contact the Firm

    Los Angeles, California--(Newsfile Corp. - January 26, 2023) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sotera Health Company ("Sotera" or "the Company") (NASDAQ: SHC) for violations of the federal securities laws.Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on November 20, 2020 (the "IPO") and/or pursuant and/or traceable to the Company's secondary public offering conducted on or around March...

    2023-01-26 12:00 PM EST